This blog serves to provide information about a common complication of sickle cell disease known as pulminary hypertension. Puluminary hypertension is a disorder in which one has elevated pulminary artery pressure and pulminary vascular resistance. Pulminary hypertension turns out to be a rising risk factor for morbidity and mortality in adults with sickle cell disease. As in other chronic haemolytic disorders an echocardiograph is very helpful in elucidating pulminary hypertension. Any insight into the disposition of the patient can decrease the progression of the disease early on. Therapy for these patients may consist of vasodilators and or antiremodiling agents depending on how severe the hypertension is. Further studies are needed to discern the necessary connections between increases in pulminary pressure on cardiopulminary function and mortality in sickle cell disease patients.